BioSpace News Archive

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its third-quarter financial results before the market opens on Tuesday, October 20, 2020. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvi

Kymanox, a full-service life sciences solutions provider supporting commercialization of vital medicines and treatments, today announced the addition of two new executives.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it will host a virtual symposium on October 21, 2020 to present ten years of world-wide clinical and real world data for its Motiva® silicone breast implants.

Endo International plc (NASDAQ: ENDP) will announce its third–quarter 2020 financial results on November 5, 2020 after the market closes and members of its senior management team will host a conference call and webcast on November 6, 2020 at 7:30am EST .

PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020.

FYR Diagnostics , a Missoula - based biotechnology company announced that it will immediately begin processing COVID-19 tests to help increase Montana’s overall testing capacity. FYR will use a test tha

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

Indigenous communities burdened with up to three times the national rates of chronic diseases now have access to an innovative health project fund established by Bimaadzwin and Boehringer Ingelheim Ltd.

Livongo to Provide Remote Monitoring, Connected Devices Powered by Advanced Data Science, and Personalized Coaching for People with Late-Stage CKD

The Southern California Biomedical Council (SoCalBio) — the voice and advocate for the bioscience and digital health industries in the Greater Los Angeles region — today announced the preliminary lineup of companies selected to present at the 22nd Annual SoCalBio Conference (www.SoCalBioInvest.com).